Eli Lilly Receivables 2010-2024 | LLY

Eli Lilly receivables for the quarter ending September 30, 2024 were $12.052B, a 16.29% increase year-over-year.

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.

Eli Lilly Receivables 2010-2024 | LLY

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B